marketing agreement

NEW YORK (GenomeWeb) – Veracyte today said that it has signed a partnership with Fleury Medicine and Health to make its Afirma Gene Expression Classifier for thyroid cancer diagnosis available to patients in Brazil.

NEW YORK (GenomeWeb) – Biometric solutions firm Morpho will market IntegenX's RapidHit DNA analysis system to law enforcement and government agencies in certain countries as part of a deal announced today.

NEW YORK (GenomeWeb News) – Medison will make available CardioDx's Corus CAD diagnostic test for obstructive coronary artery disease in Israel as part of an agreement announced today.

NEW YORK (GenomeWeb News) – BioDiscovery and N-of-One today announced a marketing agreement to provide genomic analysis interpretation solutions.

NEW YORK (GenomeWeb News) – Good Start Genetics today announced a deal with PerkinElmer to expand access to the GoodStart Select menu of genetic carrier screening tests.

NEW YORK (GenomeWeb News) – Personalized medicine firm Transgenomic today announced that it has signed a deal under which PerkinElmer will market and distribute its portfolio of molecular diagnostic oncology products in all markets outside the US.

NEW YORK (GenomeWeb News) – Metabolon and Bostwick Laboratories today announced an exclusive marketing agreement covering Metabolon's Prostarix test for stratifying prostate cancer risk.

NEW YORK (GenomeWeb News) – Enzo Biochem today said that it has signed an agreement to market Sequenom's MaterniT21 Plus test service in the northeast US.

NEW YORK (GenomeWeb News) – Tibco Software said today that it has expanded its existing relationship with PerkinElmer so that its customers can benefit from PerkinElmer's investments in product and application development in the clinical research and development arena.

NEW YORK (GenomeWeb News) – PDI and Transgenomic today announced a collaboration to commercialize Transgenomic's molecular diagnostic test that identifies specific genes that influence the safety and effectiveness of commonly used cardiovascular drugs.